OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Blastic plasmacytoid dendritic cell neoplasm frequently shows occult central nervous system involvement at diagnosis and benefits from intrathecal therapy
Lourdes Martín‐Martín, Júlia Almeida, Helena Pomares, et al.
Oncotarget (2016) Vol. 7, Iss. 9, pp. 10174-10181
Open Access | Times Cited: 77
Lourdes Martín‐Martín, Júlia Almeida, Helena Pomares, et al.
Oncotarget (2016) Vol. 7, Iss. 9, pp. 10174-10181
Open Access | Times Cited: 77
Showing 1-25 of 77 citing articles:
Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm
Naveen Pemmaraju, Andrew A. Lane, Kendra Sweet, et al.
New England Journal of Medicine (2019) Vol. 380, Iss. 17, pp. 1628-1637
Open Access | Times Cited: 341
Naveen Pemmaraju, Andrew A. Lane, Kendra Sweet, et al.
New England Journal of Medicine (2019) Vol. 380, Iss. 17, pp. 1628-1637
Open Access | Times Cited: 341
Treatment of blastic plasmacytoid dendritic cell neoplasm
Jill M. Sullivan, David A. Rizzieri
Hematology (2016) Vol. 2016, Iss. 1, pp. 16-23
Open Access | Times Cited: 92
Jill M. Sullivan, David A. Rizzieri
Hematology (2016) Vol. 2016, Iss. 1, pp. 16-23
Open Access | Times Cited: 92
Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies
Branko Cuglievan, Jeremy Connors, Jiasen He, et al.
Leukemia (2023) Vol. 37, Iss. 9, pp. 1767-1778
Open Access | Times Cited: 23
Branko Cuglievan, Jeremy Connors, Jiasen He, et al.
Leukemia (2023) Vol. 37, Iss. 9, pp. 1767-1778
Open Access | Times Cited: 23
Haploinsufficiency for NR3C1, the gene encoding the glucocorticoid receptor, in blastic plasmacytoid dendritic cell neoplasms
Anouk Emadali, Neda Hoghoughi, Samuel Duley, et al.
Blood (2016) Vol. 127, Iss. 24, pp. 3040-3053
Open Access | Times Cited: 67
Anouk Emadali, Neda Hoghoughi, Samuel Duley, et al.
Blood (2016) Vol. 127, Iss. 24, pp. 3040-3053
Open Access | Times Cited: 67
Central nervous system involvement in blastic plasmacytoid dendritic cell neoplasm
Naveen Pemmaraju, Nathaniel R. Wilson, Joseph D. Khoury, et al.
Blood (2021) Vol. 138, Iss. 15, pp. 1373-1377
Open Access | Times Cited: 41
Naveen Pemmaraju, Nathaniel R. Wilson, Joseph D. Khoury, et al.
Blood (2021) Vol. 138, Iss. 15, pp. 1373-1377
Open Access | Times Cited: 41
North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need
Naveen Pemmaraju, Hagop M. Kantarjian, Kendra Sweet, et al.
Blood (2022) Vol. 141, Iss. 6, pp. 567-578
Open Access | Times Cited: 30
Naveen Pemmaraju, Hagop M. Kantarjian, Kendra Sweet, et al.
Blood (2022) Vol. 141, Iss. 6, pp. 567-578
Open Access | Times Cited: 30
Characteristics and outcomes of patients with blastic plasmacytoid dendritic cell neoplasm treated with frontline HCVAD
Naveen Pemmaraju, Nathaniel R. Wilson, Guillermo Garcia‐Manero, et al.
Blood Advances (2022) Vol. 6, Iss. 10, pp. 3027-3035
Open Access | Times Cited: 28
Naveen Pemmaraju, Nathaniel R. Wilson, Guillermo Garcia‐Manero, et al.
Blood Advances (2022) Vol. 6, Iss. 10, pp. 3027-3035
Open Access | Times Cited: 28
LXR agonist treatment of blastic plasmacytoid dendritic cell neoplasm restores cholesterol efflux and triggers apoptosis
Adam Ceroi, David Masson, Anne Roggy, et al.
Blood (2016) Vol. 128, Iss. 23, pp. 2694-2707
Open Access | Times Cited: 55
Adam Ceroi, David Masson, Anne Roggy, et al.
Blood (2016) Vol. 128, Iss. 23, pp. 2694-2707
Open Access | Times Cited: 55
Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm: A Systematic Literature Review
Marie JeongMin Kim, Ahmed Nasr, Bilaal Kabir, et al.
Journal of Pediatric Hematology/Oncology (2017) Vol. 39, Iss. 7, pp. 528-537
Closed Access | Times Cited: 53
Marie JeongMin Kim, Ahmed Nasr, Bilaal Kabir, et al.
Journal of Pediatric Hematology/Oncology (2017) Vol. 39, Iss. 7, pp. 528-537
Closed Access | Times Cited: 53
Blastic Plasmacytoid Dendritic Cell Neoplasm
Joseph D. Khoury
Current Hematologic Malignancy Reports (2018) Vol. 13, Iss. 6, pp. 477-483
Closed Access | Times Cited: 52
Joseph D. Khoury
Current Hematologic Malignancy Reports (2018) Vol. 13, Iss. 6, pp. 477-483
Closed Access | Times Cited: 52
Blastic Plasmacytoid Dendritic Cell Neoplasm–Current Insights
Sangeetha Venugopal, Selena Zhou, Siraj M. El Jamal, et al.
Clinical Lymphoma Myeloma & Leukemia (2019) Vol. 19, Iss. 9, pp. 545-554
Closed Access | Times Cited: 46
Sangeetha Venugopal, Selena Zhou, Siraj M. El Jamal, et al.
Clinical Lymphoma Myeloma & Leukemia (2019) Vol. 19, Iss. 9, pp. 545-554
Closed Access | Times Cited: 46
Unmet Clinical Needs and Management Recommendations for Blastic Plasmacytoid Dendritic Cell Neoplasm: A Consensus-based Position Paper From an Ad Hoc International Expert Panel
Livio Pagano, Pier Luigi Zinzani, Stefano Pileri, et al.
HemaSphere (2023) Vol. 7, Iss. 3, pp. e841-e841
Open Access | Times Cited: 13
Livio Pagano, Pier Luigi Zinzani, Stefano Pileri, et al.
HemaSphere (2023) Vol. 7, Iss. 3, pp. e841-e841
Open Access | Times Cited: 13
Blastic Plasmacytoid Dendritic Cell Neoplasm: A Comprehensive Review of the Disease, Central Nervous System Presentations, and Treatment Strategies
Shefali Mehra, Justin Taylor
Cells (2024) Vol. 13, Iss. 3, pp. 243-243
Open Access | Times Cited: 5
Shefali Mehra, Justin Taylor
Cells (2024) Vol. 13, Iss. 3, pp. 243-243
Open Access | Times Cited: 5
Diagnostic approach to blastic plasmacytoid dendritic cell neoplasm: historical perspectives and current understanding
Kana Sakamoto, Kengo Takeuchi
Journal of Clinical and Experimental Hematopathology (2025) Vol. 65, Iss. 1, pp. 1-16
Open Access
Kana Sakamoto, Kengo Takeuchi
Journal of Clinical and Experimental Hematopathology (2025) Vol. 65, Iss. 1, pp. 1-16
Open Access
NPM1 mutation frequency and protein in Cutaneous Blastic Plasmacytoid Dendritic Cell Neoplasms
Hanan Hamdan, Alexa J. Siddon, Maximiliano Ramia de, et al.
Human Pathology (2025), pp. 105766-105766
Closed Access
Hanan Hamdan, Alexa J. Siddon, Maximiliano Ramia de, et al.
Human Pathology (2025), pp. 105766-105766
Closed Access
Blastic plasmacytoid dendritic cell neoplasm: diagnosis, manifestations, and treatment
Kendra Sweet
Current Opinion in Hematology (2020) Vol. 27, Iss. 2, pp. 103-107
Closed Access | Times Cited: 37
Kendra Sweet
Current Opinion in Hematology (2020) Vol. 27, Iss. 2, pp. 103-107
Closed Access | Times Cited: 37
Novel Therapeutic Approaches in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Era of Targeted Therapy
Nathaniel R. Wilson, Marina Konopleva, Joseph D. Khoury, et al.
Clinical Lymphoma Myeloma & Leukemia (2021) Vol. 21, Iss. 11, pp. 734-740
Closed Access | Times Cited: 29
Nathaniel R. Wilson, Marina Konopleva, Joseph D. Khoury, et al.
Clinical Lymphoma Myeloma & Leukemia (2021) Vol. 21, Iss. 11, pp. 734-740
Closed Access | Times Cited: 29
Tagraxofusp, a first‐in‐class CD123‐targeted agent: Five‐year postapproval comprehensive review of the literature
Wei‐Ying Jen, Marina Konopleva, Naveen Pemmaraju
Cancer (2024) Vol. 130, Iss. 13, pp. 2260-2271
Closed Access | Times Cited: 4
Wei‐Ying Jen, Marina Konopleva, Naveen Pemmaraju
Cancer (2024) Vol. 130, Iss. 13, pp. 2260-2271
Closed Access | Times Cited: 4
Blastic Plasmacytoid Dendritic Cell Neoplasm
Daniel Kerr, Ling Zhang, Lubomir Sokol
Current Treatment Options in Oncology (2019) Vol. 20, Iss. 1
Closed Access | Times Cited: 35
Daniel Kerr, Ling Zhang, Lubomir Sokol
Current Treatment Options in Oncology (2019) Vol. 20, Iss. 1
Closed Access | Times Cited: 35
Blastic plasmacytoid dendritic cell neoplasm (BPDCN ): A promising future in the era of targeted therapeutics
Ijele Adimora, Nathaniel R. Wilson, Naveen Pemmaraju
Cancer (2022) Vol. 128, Iss. 16, pp. 3019-3026
Closed Access | Times Cited: 17
Ijele Adimora, Nathaniel R. Wilson, Naveen Pemmaraju
Cancer (2022) Vol. 128, Iss. 16, pp. 3019-3026
Closed Access | Times Cited: 17
An Analysis of the Pathologic Features of Blastic Plasmacytoid Dendritic Cell Neoplasm Based on a Comprehensive Literature Database of Cases
Robert S. Ohgami, Phyu P. Aung, Alejandro A. Gru, et al.
Archives of Pathology & Laboratory Medicine (2022) Vol. 147, Iss. 7, pp. 837-846
Open Access | Times Cited: 17
Robert S. Ohgami, Phyu P. Aung, Alejandro A. Gru, et al.
Archives of Pathology & Laboratory Medicine (2022) Vol. 147, Iss. 7, pp. 837-846
Open Access | Times Cited: 17
Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations
Evgenii Shumilov, Paolo Mazzeo, Susanne Ghandili, et al.
Annals of Hematology (2024) Vol. 103, Iss. 5, pp. 1587-1599
Open Access | Times Cited: 3
Evgenii Shumilov, Paolo Mazzeo, Susanne Ghandili, et al.
Annals of Hematology (2024) Vol. 103, Iss. 5, pp. 1587-1599
Open Access | Times Cited: 3
Tagraxofusp for Blastic Plasmacytoid Dendritic Cell Neoplasm
Danielle Hammond, Naveen Pemmaraju
Hematology/Oncology Clinics of North America (2020) Vol. 34, Iss. 3, pp. 565-574
Closed Access | Times Cited: 24
Danielle Hammond, Naveen Pemmaraju
Hematology/Oncology Clinics of North America (2020) Vol. 34, Iss. 3, pp. 565-574
Closed Access | Times Cited: 24
Tagraxofusp for blastic plasmacytoid dendritic cell neoplasm
Marlise R. Luskin, Andrew A. Lane
Haematologica (2023)
Open Access | Times Cited: 8
Marlise R. Luskin, Andrew A. Lane
Haematologica (2023)
Open Access | Times Cited: 8
Clinical diversity and treatment approaches to blastic plasmacytoid dendritic cell neoplasm: a retrospective multicentre study
Marie‐Charlotte Brüggen, Julia Valencak, R. Stranzenbach, et al.
Journal of the European Academy of Dermatology and Venereology (2020) Vol. 34, Iss. 7, pp. 1489-1495
Open Access | Times Cited: 23
Marie‐Charlotte Brüggen, Julia Valencak, R. Stranzenbach, et al.
Journal of the European Academy of Dermatology and Venereology (2020) Vol. 34, Iss. 7, pp. 1489-1495
Open Access | Times Cited: 23
